Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1631

1.

The predominance of nucleotidyl activation in bacterial phosphonate biosynthesis.

Rice K, Batul K, Whiteside J, Kelso J, Papinski M, Schmidt E, Pratasouskaya A, Wang D, Sullivan R, Bartlett C, Weadge JT, Van der Kamp MW, Moreno-Hagelsieb G, Suits MD, Horsman GP.

Nat Commun. 2019 Aug 16;10(1):3698. doi: 10.1038/s41467-019-11627-6.

PMID:
31420548
2.

Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathies.

Dubey D, David WS, Amato AA, Reynolds KL, Clement NF, Chute DF, Cohen JV, Lawrence DP, Mooradian MJ, Sullivan RJ, Guidon AC.

Neurology. 2019 Aug 12. pii: 10.1212/WNL.0000000000008091. doi: 10.1212/WNL.0000000000008091. [Epub ahead of print]

PMID:
31405908
3.

Normalizing Plasma Renin Activity in Experimental Dilated Cardiomyopathy: Effects on Edema, Cachexia, and Survival.

Sullivan RD, Mehta RM, Tripathi R, Gladysheva IP, Reed GL.

Int J Mol Sci. 2019 Aug 9;20(16). pii: E3886. doi: 10.3390/ijms20163886.

4.

MicroRNA-142 Is Critical for the Homeostasis and Function of Type 1 Innate Lymphoid Cells.

Berrien-Elliott MM, Sun Y, Neal C, Ireland A, Trissal MC, Sullivan RP, Wagner JA, Leong JW, Wong P, Mah-Som AY, Wong TN, Schappe T, Keppel CR, Cortez VS, Stamatiades EG, Li MO, Colonna M, Link DC, French AR, Cooper MA, Wang WL, Boldin MP, Reddy P, Fehniger TA.

Immunity. 2019 Aug 2. pii: S1074-7613(19)30286-9. doi: 10.1016/j.immuni.2019.06.016. [Epub ahead of print]

PMID:
31402259
5.

Cancer control in small island nations: from local challenges to global action.

Sarfati D, Dyer R, Vivili P, Herman J, Spence D, Sullivan R, Weller D, Bray F, Hill S, Bates C, Foliaki S, Palafox N, Luciani S, Ekeroma A, Hospedales J.

Lancet Oncol. 2019 Aug 5. pii: S1470-2045(19)30511-X. doi: 10.1016/S1470-2045(19)30511-X. [Epub ahead of print] Review.

PMID:
31395475
6.

A fatty acid oxidation-dependent metabolic shift regulates the adaptation of BRAF-mutated melanoma to MAPK inhibitors.

Aloia A, Müllhaupt D, Chabbert CD, Eberhart T, Flueckiger S, Vukolic A, Eichhoff OM, Irmisch A, Alexander LT, Scibona E, Frederick DT, Miao B, Tian T, Cheng C, Kwong LN, Wei Z, Sullivan RJ, Boland GM, Herlyn M, Flaherty KT, Zamboni N, Dummer R, Zhang G, Levesque MP, Krek W, Kovacs WJ.

Clin Cancer Res. 2019 Aug 2. pii: clincanres.0253.2019. doi: 10.1158/1078-0432.CCR-19-0253. [Epub ahead of print]

PMID:
31375515
7.

Offline Next Generation Metagenomics Sequence Analysis Using MinION Detection Software (MINDS).

Deshpande SV, Reed TM, Sullivan RF, Kerkhof LJ, Beigel KM, Wade MM.

Genes (Basel). 2019 Jul 30;10(8). pii: E578. doi: 10.3390/genes10080578.

8.

The east London geriatric in situ simulation (ELGIS) programme: implementing in situ simulation in elderly care in two district general hospitals.

Walker G, Dormandy L, Quah C, Sullivan R, Dasgupta D.

Future Healthc J. 2019 Mar;6(Suppl 1):165. doi: 10.7861/futurehosp.6-1-s165. No abstract available.

9.

PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance.

Verma V, Shrimali RK, Ahmad S, Dai W, Wang H, Lu S, Nandre R, Gaur P, Lopez J, Sade-Feldman M, Yizhak K, Bjorgaard SL, Flaherty KT, Wargo JA, Boland GM, Sullivan RJ, Getz G, Hammond SA, Tan M, Qi J, Wong P, Merghoub T, Wolchok J, Hacohen N, Janik JE, Mkrtichyan M, Gupta S, Khleif SN.

Nat Immunol. 2019 Jul 29. doi: 10.1038/s41590-019-0441-y. [Epub ahead of print]

PMID:
31358999
10.

First- and Second-Hand Experiences of Enacted Stigma Among LGBTQ Youth.

Gower AL, Valdez CAB, Watson RJ, Eisenberg ME, Mehus CJ, Saewyc EM, Corliss HL, Sullivan R, Porta CM.

J Sch Nurs. 2019 Jul 23:1059840519863094. doi: 10.1177/1059840519863094. [Epub ahead of print]

PMID:
31337243
11.

Parental presence switches avoidance to attraction learning in children.

Tottenham N, Shapiro M, Flannery J, Caldera C, Sullivan RM.

Nat Hum Behav. 2019 Jul 22. doi: 10.1038/s41562-019-0656-9. [Epub ahead of print]

PMID:
31332302
12.

Medical Oncology Workload in Europe: One Continent, Several Worlds.

Seruga B, Sullivan R, Fundytus A, Hopman WM, Ocana A, Joffe J, Bodoky G, Le Tourneau C, Vanderpuye V, Lopes G, Hammad N, Sengar M, Brundage MD, Booth CM.

Clin Oncol (R Coll Radiol). 2019 Jul 16. pii: S0936-6555(19)30278-X. doi: 10.1016/j.clon.2019.06.017. [Epub ahead of print]

PMID:
31324474
13.

Screening for Anaplastic Lymphoma Kinase (ALK) gene rearrangements in non-small cell lung cancer (NSCLC) in New Zealand.

McKeage MJ, Tin Tin S, Khwaounjoo P, Sheath K, Dixon-McIver A, Ng D, Sullivan R, Cameron L, Shepherd P, Laking GR, Kingston N, Strauss M, Lewis C, Elwood M, Love DR.

Intern Med J. 2019 Jul 18. doi: 10.1111/imj.14435. [Epub ahead of print]

PMID:
31318119
14.

Infant Trauma Alters Social Buffering of Threat Learning: Emerging Role of Prefrontal Cortex in Preadolescence.

Robinson-Drummer PA, Opendak M, Blomkvist A, Chan S, Tan S, Delmer C, Wood K, Sloan A, Jacobs L, Fine E, Chopra D, Sandler C, Kamenetzky G, Sullivan RM.

Front Behav Neurosci. 2019 Jun 21;13:132. doi: 10.3389/fnbeh.2019.00132. eCollection 2019.

15.

Development of Threat Expression Following Infant Maltreatment: Infant and Adult Enhancement but Adolescent Attenuation.

Junod A, Opendak M, LeDoux JE, Sullivan RM.

Front Behav Neurosci. 2019 Jun 25;13:130. doi: 10.3389/fnbeh.2019.00130. eCollection 2019.

16.

Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium.

Amaria RN, Menzies AM, Burton EM, Scolyer RA, Tetzlaff MT, Antdbacka R, Ariyan C, Bassett R, Carter B, Daud A, Faries M, Fecher LA, Flaherty KT, Gershenwald JE, Hamid O, Hong A, Kirkwood JM, Lo S, Margolin K, Messina J, Postow MA, Rizos H, Ross MI, Rozeman EA, Saw RPM, Sondak V, Sullivan RJ, Taube JM, Thompson JF, van de Wiel BA, Eggermont AM, Davies MA; International Neoadjuvant Melanoma Consortium members, Ascierto PA, Spillane AJ, van Akkooi ACJ, Wargo JA, Blank CU, Tawbi HA, Long GV.

Lancet Oncol. 2019 Jul;20(7):e378-e389. doi: 10.1016/S1470-2045(19)30332-8. Review.

PMID:
31267972
17.

Renin Activity in Heart Failure with Reduced Systolic Function-New Insights.

Sullivan RD, Mehta RM, Tripathi R, Reed GL, Gladysheva IP.

Int J Mol Sci. 2019 Jun 28;20(13). pii: E3182. doi: 10.3390/ijms20133182. Review.

18.

Hypophysitis secondary to nivolumab and pembrolizumab is a clinical entity distinct from ipilimumab-associated hypophysitis.

Faje A, Reynolds K, Zubiri L, Lawrence D, Cohen J, Sullivan R, Nachtigall LB, Tritos N.

Eur J Endocrinol. 2019 Jun 1. pii: EJE-19-0238.R1. doi: 10.1530/EJE-19-0238. [Epub ahead of print]

PMID:
31176301
19.

Atezolizumab plus cobimetinib and vemurafenib in BRAF-mutated melanoma patients.

Sullivan RJ, Hamid O, Gonzalez R, Infante JR, Patel MR, Hodi FS, Lewis KD, Tawbi HA, Hernandez G, Wongchenko MJ, Chang Y, Roberts L, Ballinger M, Yan Y, Cha E, Hwu P.

Nat Med. 2019 Jun;25(6):929-935. doi: 10.1038/s41591-019-0474-7. Epub 2019 Jun 6.

PMID:
31171876
20.

Molecular biomarkers and precision medicine in colorectal cancer: a systematic review of health economic analyses.

Henderson R, French D, Sullivan R, Maughan T, Clarke M, Lawler M.

Oncotarget. 2019 May 21;10(36):3408-3423. doi: 10.18632/oncotarget.26909. eCollection 2019 May 21. Review.

21.

India's new health scheme: what does it mean for cancer care?

Caduff C, Booth CM, Pramesh CS, Sullivan R.

Lancet Oncol. 2019 Jun;20(6):757-758. doi: 10.1016/S1470-2045(19)30322-5. No abstract available.

PMID:
31162087
22.

Back to the Future: Rethinking and Retooling IL2 in the Immune Checkpoint Inhibitor Era.

Sullivan RJ.

Cancer Discov. 2019 Jun;9(6):694-695. doi: 10.1158/2159-8290.CD-19-0412.

PMID:
31160329
23.

Cancer care workforce in Africa: perspectives from a global survey.

Vanderpuye V, Hammad N, Martei Y, Hopman WM, Fundytus A, Sullivan R, Seruga B, Lopes G, Sengar M, Brundage MD, Booth CM.

Infect Agent Cancer. 2019 May 21;14:11. doi: 10.1186/s13027-019-0227-8. eCollection 2019.

24.

Proteomic markers of low and high fertility bovine spermatozoa separated by Percoll gradient.

D'Amours O, Calvo É, Bourassa S, Vincent P, Blondin P, Sullivan R.

Mol Reprod Dev. 2019 Aug;86(8):999-1012. doi: 10.1002/mrd.23174. Epub 2019 May 27.

PMID:
31134708
25.

Cancer control in low- and middle-income countries: time for action.

Hack B, Piddock K, Stanway S, Balachandran K, Board R, Chopra N, Okonji D, Sirohi B, Sullivan R, Wakeham K.

J R Soc Med. 2019 Jun;112(6):213-217. doi: 10.1177/0141076819843653. Epub 2019 May 24. No abstract available.

PMID:
31124403
26.

Creating a low-cost virtual reality surgical simulation to increase surgical oncology capacity and capability.

Parham G, Bing EG, Cuevas A, Fisher B, Skinner J, Mwanahamuntu M, Sullivan R.

Ecancermedicalscience. 2019 Mar 18;13:910. doi: 10.3332/ecancer.2019.910. eCollection 2019.

27.

Financial Toxicity After Cancer in a Setting With Universal Health Coverage: A Call for Urgent Action.

Bhoo-Pathy N, Ng CW, Lim GC, Tamin NSI, Sullivan R, Bhoo-Pathy NT, Abdullah MM, Kimman M, Subramaniam S, Saad M, Taib NA, Chang KM, Goh PP, Yip CH.

J Oncol Pract. 2019 Jun;15(6):e537-e546. doi: 10.1200/JOP.18.00619. Epub 2019 May 21.

PMID:
31112479
28.

Immunotherapeutic strategies for cutaneous squamous cell carcinoma prevention in xeroderma pigmentosum.

Ameri AH, Mooradian MJ, Emerick KS, Park JC, Wirth LJ, Asgari MM, Tsao H, Lawrence D, Sullivan RJ, Demehri S.

Br J Dermatol. 2019 May 18. doi: 10.1111/bjd.18144. [Epub ahead of print] No abstract available.

PMID:
31102460
29.

Frontline Therapy for BRAF-Mutated Metastatic Melanoma: How Do You Choose, and Is There One Correct Answer?

Pavlick AC, Fecher L, Ascierto PA, Sullivan RJ.

Am Soc Clin Oncol Educ Book. 2019 Jan;39:564-571. doi: 10.1200/EDBK_243071. Epub 2019 May 17.

PMID:
31099689
30.

Modelling bistable tumour population dynamics to design effective treatment strategies.

Akhmetzhanov AR, Kim JW, Sullivan R, Beckman RA, Tamayo P, Yeang CH.

J Theor Biol. 2019 Aug 7;474:88-102. doi: 10.1016/j.jtbi.2019.05.005. Epub 2019 May 9.

31.

Children of Military Families.

Sullivan RM, Cozza SJ, Dougherty JG.

Child Adolesc Psychiatr Clin N Am. 2019 Jul;28(3):337-348. doi: 10.1016/j.chc.2019.02.004. Epub 2019 Apr 4. Review.

PMID:
31076112
32.

Using Low-Cost Virtual Reality Simulation to Build Surgical Capacity for Cervical Cancer Treatment.

Bing EG, Parham GP, Cuevas A, Fisher B, Skinner J, Mwanahamuntu M, Sullivan R.

J Glob Oncol. 2019 May;5:1-7. doi: 10.1200/JGO.18.00263.

33.

Gestational Age-Dependent Interplay between Endocannabinoid Receptors and Alcohol in Fetal Cerebral Arteries.

Simakova M, Tobiasz A, Sullivan RD, Bisen S, Duncan J, Sullivan JP, Davison S, Tate DL, Barnett S, Mari G, Dopico AM, Bukiya AN.

J Drug Alcohol Res. 2019;8. pii: 236068. doi: 10.4303/jdar/236068.

34.

Do not use robotic surgery in oncology patients when conventional surgical approaches are equally effective - Authors' reply.

Pramesh CS, Sullivan R, Booth CM.

Lancet Oncol. 2019 May;20(5):e241. doi: 10.1016/S1470-2045(19)30247-5. No abstract available.

PMID:
31044716
35.

Revisiting structure/functions of the human epididymis.

Sullivan R, Légaré C, Lamontagne-Proulx J, Breton S, Soulet D.

Andrology. 2019 Sep;7(5):748-757. doi: 10.1111/andr.12633. Epub 2019 Apr 29. Review.

PMID:
31033221
36.

Author Correction: Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia.

Cortese A, Simone R, Sullivan R, Vandrovcova J, Tariq H, Yau WY, Humphrey J, Jaunmuktane Z, Sivakumar P, Polke J, Ilyas M, Tribollet E, Tomaselli PJ, Devigili G, Callegari I, Versino M, Salpietro V, Efthymiou S, Kaski D, Wood NW, Andrade NS, Buglo E, Rebelo A, Rossor AM, Bronstein A, Fratta P, Marques WJ, Züchner S, Reilly MM, Houlden H.

Nat Genet. 2019 May;51(5):920. doi: 10.1038/s41588-019-0422-y.

PMID:
31028356
37.

Analyzing Secondary Structure Patterns in DNA Aptamers Identified via CompELS.

Sullivan R, Adams MC, Naik RR, Milam VT.

Molecules. 2019 Apr 21;24(8). pii: E1572. doi: 10.3390/molecules24081572.

38.

The metastatic dissemination of a squamous cell carcinoma arising from an epidermal cyst and subsequent failure to respond to programmed death 1 inhibition.

Lumish MA, Anderson MA, Rush PS, Fintelmann FJ, Duncan L, Sullivan RJ, Mooradian MJ.

JAAD Case Rep. 2019 Apr 5;5(4):375-378. doi: 10.1016/j.jdcr.2019.01.032. eCollection 2019 Apr. No abstract available.

39.

Developments in the Space of New MAPK Pathway Inhibitors for BRAF-Mutant Melanoma.

Cohen JV, Sullivan RJ.

Clin Cancer Res. 2019 Apr 16. doi: 10.1158/1078-0432.CCR-18-0836. [Epub ahead of print] Review.

PMID:
30992297
40.

What to Do When Anti-PD-1 Therapy Fails in Patients With Melanoma.

Mooradian MJ, Sullivan RJ.

Oncology (Williston Park). 2019 Apr 15;33(4):141-8. Review.

41.

Single-Use Custom Instrumentation in Total Knee Arthroplasty: Effect on In-Hospital Complications, Length of Stay, and Discharge Disposition.

Harold RE, Macleod J, Butler BA, Sullivan R, Beal MD, Manning DW.

Orthopedics. 2019 Apr 9:1-5. doi: 10.3928/01477447-20190403-03. [Epub ahead of print]

PMID:
30964541
42.

Dialysis Is Not Associated with Increased Risk of Perioperative Complications in TKA Patients after Adjusting for Pertinent Confounders.

Gwam CU, Sultan A, Rosas S, Sullivan R, Seem M, Ohanale C, Plate JF.

J Knee Surg. 2019 Apr 8. doi: 10.1055/s-0039-1683975. [Epub ahead of print]

PMID:
30959539
43.

Relationship of the Posterior Condylar Line and the Transepicondylar Axis: A CT-Based Evaluation.

Fitz DW, Johnson DJ, Hartwell MH, Sullivan R, Keller TJ, Manning DW.

J Knee Surg. 2019 Apr 8. doi: 10.1055/s-0039-1685146. [Epub ahead of print]

PMID:
30959538
44.

Using Ionic Liquids To Study the Migration of Semivolatile Organic Vapors in Smog Chamber Experiments.

Ye Q, Sullivan RC, Donahue NM.

J Phys Chem A. 2019 May 2;123(17):3887-3892. doi: 10.1021/acs.jpca.9b02847. Epub 2019 Apr 22.

PMID:
30950612
45.

Dynamics of the Ghrelin/Growth Hormone Secretagogue Receptor System in the Human Heart Before and After Cardiac Transplantation.

Sullivan R, Randhawa VK, Stokes A, Wu D, Lalonde T, Kiaii B, Luyt L, Wisenberg G, Dhanvantari S.

J Endocr Soc. 2019 Feb 14;3(4):748-762. doi: 10.1210/js.2018-00393. eCollection 2019 Apr 1.

46.

Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia.

Cortese A, Simone R, Sullivan R, Vandrovcova J, Tariq H, Yau WY, Humphrey J, Jaunmuktane Z, Sivakumar P, Polke J, Ilyas M, Tribollet E, Tomaselli PJ, Devigili G, Callegari I, Versino M, Salpietro V, Efthymiou S, Kaski D, Wood NW, Andrade NS, Buglo E, Rebelo A, Rossor AM, Bronstein A, Fratta P, Marques WJ, Züchner S, Reilly MM, Houlden H.

Nat Genet. 2019 Apr;51(4):649-658. doi: 10.1038/s41588-019-0372-4. Epub 2019 Mar 29. Erratum in: Nat Genet. 2019 May;51(5):920.

PMID:
30926972
47.

A narrative review of health research capacity strengthening in low and middle-income countries: lessons for conflict-affected areas.

Bowsher G, Papamichail A, El Achi N, Ekzayez A, Roberts B, Sullivan R, Patel P.

Global Health. 2019 Mar 26;15(1):23. doi: 10.1186/s12992-019-0465-y. Review.

48.

Do patients with severe poststroke communication difficulties have a higher incidence of falls during inpatient rehabilitation? A retrospective cohort study.

Sullivan R, Harding K.

Top Stroke Rehabil. 2019 May;26(4):288-293. doi: 10.1080/10749357.2019.1591689. Epub 2019 Mar 20.

PMID:
30890038
49.

Unique infant neurobiology produces distinctive trauma processing.

Opendak M, Sullivan RM.

Dev Cogn Neurosci. 2019 Apr;36:100637. doi: 10.1016/j.dcn.2019.100637. Epub 2019 Mar 12. Review.

50.

Autoimmune genetic risk variants as germline biomarkers of response to melanoma immune-checkpoint inhibition.

Chat V, Ferguson R, Simpson D, Kazlow E, Lax R, Moran U, Pavlick A, Frederick D, Boland G, Sullivan R, Ribas A, Flaherty K, Osman I, Weber J, Kirchhoff T.

Cancer Immunol Immunother. 2019 Jun;68(6):897-905. doi: 10.1007/s00262-019-02318-8. Epub 2019 Mar 12.

PMID:
30863922

Supplemental Content

Loading ...
Support Center